The medical world in 2026 is experiencing a seismic shift in how surgical and trauma bleeding is managed, with the global value of specialized clotting agents now reaching $2.36 billion. For decades, hospitals relied on frozen blood components that required lengthy thawing times and carried risks of viral transmission, but 2026 has marked the widespread adoption of standardized fibrinogen...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
thai
English
French
Spanish
Italiano
Romaian
Portuguese (Brazil)
china